Here’s to a 2026 Full of Progress, Collaboration and Innovation !
As we step into the new year, all of us at iMEAN would like to extend our warmest wishes for a joyous and prosperous 2025 to all our partners, collaborators, and community. As we step into 2026, the entire iMEAN team would like to extend our warmest wishes for a healthy, inspiring and successful year ahead.
The past year marked an important milestone in iMEAN’s journey. 2025 was a year of exploration, growth and international validation. Thanks to the trust of our clients and partners we strengthened both our impact and our cutting edge technology.
2025 confirmed the relevance and robustness of iMEAN’s approach to bioprocess modelling and simulation.
- +30% growth in activity, reflecting the increasing trust and impact of our predictive tools
- 256 organisms modelled, expanding our biological and industrial knowledge base
- A team of 19 talented experts, combining scientific excellence, software development and industrial insight
- Exploration of Brazil and Japan market.
This collective effort allowed us to engage in ambitious projects, explore new markets and validate iMEAN’s international presence.
2026 : A Year of Expansion Consolidation
After a phase of exploration, 2026 opens a new chapter focused on expansion consolidation.
We intend to deploy more software platforms, with implementation of new advanced simulation modules, Strain Library management software, Digital twin, as well as client data structuring. Several projects are already underway with major Industrial groups, reinforcing our ambition to position iMEAN as a key digital enabler for biotech and the growing adoption of digital tools in biotech.
Having validated our international footprint in 2025, we will be pursuing a phase of strategic expansion consolidation with upcoming events, such as BIOKET this March, providing key opportunities to further anchor our presence within the global European biotech ecosystem.
In parallel, we aim to open new training and consulting offers, sharing our expertise in simulation-driven approaches and supporting large organisations in the operational structuring of data for digital applications.
Our goal is to help large industrial players not only design, but also operationally deploy robust data-driven strategies.
Finally, we will communicate soon about new strategic partnerships, aimed at reinforcing the deployment of iMEAN’s technology across the entire biotech value chain, from equipment manufacturers to downstream processing.
Building the Future, Together
More than ever, iMEAN’s ambition is driven by collaboration, scientific rigor and industrial impact.
We sincerely thank our clients and partners for their continued trust and commitment and hope to renew our collaborations in 2026.
The entire iMEAN team is looking forward to shaping 2026 with you, transforming data into actionable knowledge and simulation into performance !